Recent Updates
Recently added Catalysts
RIGL Positive Sentiment Score: 60/100

Rigel to Present at the Jefferies Global Healthcare Conference

Wednesday, May 28, 2025 1 min read
Key Takeaway: Rigel Pharmaceuticals, Inc. has announced that its CEO, Raul Rodriguez, will provide a company overview at the upcoming Jefferies Global Healthcare Conference on June 4, 2025. This event is an opportunity for Rigel to showcase its commitment to developing therapies for hematologic disorders and cancer. Investors can access the live webcast through the Investor Relations section of Rigel's website. The company's focus on significant health challenges highlights its dedication to improving patient outcomes.

Conference Participation Details

Jefferies Global Healthcare Conference
Date: November 18, 2025
Time: 11:30 a.m. GMT / 6:30 a.m. ET
Location: London
Format: Fireside Chat

How to Access

Investors and the general public can listen to both sessions live at:

https://investor.viatris.com

Archived versions will be available following the live events for a limited time.

Market Sentiment Analysis

POSITIVE FACTORS

  • Rigel is actively engaging with investors through conference presentations.
  • The company focuses on significant health issues in hematology and cancer.
  • Raul Rodriguez, as CEO, is representing the company, which indicates leadership involvement.

Full Press Release Details

SOUTH SAN FRANCISCO, Calif., May 28, 2025 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced that Raul Rodriguez, the company's president and CEO, will present a company overview at the Jefferies Global Healthcare Conference on Wednesday, June 4, 2025 at 12:50 p.m. ET in New York, NY.
To access the live webcast or archived recording, visit the Investor Relations section of the company's website at www.rigel.com. Please connect to Rigel's website prior to the start of the live webcast to allow for any software downloads.
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer. Founded in 1996, Rigel is based in South San Francisco, California. For more information on Rigel, the Company's marketed products and pipeline of potential products, visit www.rigel.com.
Contact for Investors & Media:
Rigel Pharmaceuticals, Inc.
SOURCE Rigel Pharmaceuticals, Inc.

21 %

more press release views with

Frequently Asked Questions

When will Rigel Pharmaceuticals present at the Jefferies Conference?

Rigel Pharmaceuticals will present on June 4, 2025, at 12:50 p.m. ET.

Where can I access Rigel's presentation webcast?

The live webcast can be accessed at Rigel's Investor Relations section on their website.

What is the focus of Rigel Pharmaceuticals?

Rigel Pharmaceuticals focuses on hematologic disorders and cancer treatments.

When was Rigel Pharmaceuticals founded?

Rigel Pharmaceuticals was founded in 1996.

Where is Rigel Pharmaceuticals located?

Rigel Pharmaceuticals is based in South San Francisco, California.

Tags: RIGL Viatris Investor Conferences Healthcare Rigel Pharmaceuticals healthcare conference hematic disorders cancer
Last updated: May 28, 2025

Conference Timeline

Nov 11, 2025
UBS Global Healthcare Conference
8:45 AM ET • Fireside Chat
Nov 18, 2025
Jefferies Global Healthcare
11:30 AM GMT • London